CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 182 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Key inclusion· 3
  • ✓Age 18 years or older
  • ✓Suspected or confirmed diagnosis of lung or esophageal cancer
  • ✓Able to complete questionnaires
Key exclusion· 1
  • ✕Unwilling or unable to answer questionnaires

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02239328
NCT02239328N/ACompleted
CompareCT.gov

A Study of Patient-reported Outcomes in Patients With Lung or Esophageal Cancer

University of Virginia·observational·Posted Sep 12, 2014·Updated Oct 26, 2018

In Brief

An observational study for Lung Cancer and Esophageal Cancer. Completed, enrolled 182 participants across 1 site.

Detailed Summary

This survey study is looking to determine if patient reported outcomes(using the PROMIS survey) will vary according to the presence of recurrent or metastatic lung or esophageal cancer.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLung Cancer, Esophageal Cancer
CountriesUnited States
CollaboratorsAlliance for Clinical Trials in Oncology, Patient-Centered Outcomes Research Institute

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 12, 2014
Enrollment StartAug 1, 2014
Primary CompletionJun 1, 2017
Study CompletionJul 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 11.8 years ago